Borrelia burgdorferi induces matrix metalloproteinases by neural cultures

Journal of Neuroscience Research

Volumn 58, Issue 6, 1999, Pages 779-790

  Perides, George ^a,b   Tanner Brown, Linda M ^b   Eskildsen, Manuel A ^b   Klempner, Mark S ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Astrocytes; Lyme disease; Neuroborreliosis

Indexed keywords

GELATINASE A; GELATINASE B;

ANIMAL CELL; ARTICLE; ASTROCYTE; BORRELIA BURGDORFERI; CELL SPECIFICITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; ENZYME INDUCTION; HUMAN; HUMAN CELL; LYME DISEASE; NERVE CELL CULTURE; NEUROPATHOLOGY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; SPECIES DIFFERENCE;

ANIMALS; ASTROCYTES; BORRELIA BURGDORFERI GROUP; CELL CULTURE TECHNIQUES; CENTRAL NERVOUS SYSTEM; HUMANS; LYME DISEASE; MATRIX METALLOPROTEINASE 9; NEURONS; RATS; RNA, MESSENGER;

EID: 0033573307     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19991215)58:6<779::AID-JNR5>3.0.CO;2-L     Document Type: Article

References (68)

1. Anthony DC, Ferguson B, Matyzak MK, Miller KM, Esiri MM, Perry VH. 1997. Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke. Neuropathol Appl Neurobiol 23:406-415.
2. Asher RA, Bignami A. 1991. Localization of hyaluronate in primary glial cell cultures derived from newborn rat brain. Exp Cell Res 195:401-411.
3. Asher RA, Bignami A. 1992. Hyaluronate binding and CD44 expression in human glioblastoma cells and astrocytes. Exp Cell Res 203:80-90.
4. Backstrom JR, Tokes ZA. 1995. The 84-kDa form of human matrix metalloproteinase-9 degrades substance P and gelatin. J Neurochem 64:1312-1318.
5. Backstrom JR, Miller CA, Tokes ZA. 1992. Characterization of neutral proteinases from Alzheimer-affected and control brain specimens: identification of calcium-dependent metalloproteinases from the hippocampus. J Neurochem 58:983-992.
6. Barbour A. 1984. Isolation and cultivation of Lyme disease spirochaetes. Yale J Biol Med 57:521-525.
7. Belman AL, Coyle PK, Roue C, Cantos E. 1992. MRI findings in children infected by Borrelia burgdorferi. Pediatr Neurol 8:428-431.
8. Berger BW, Johnson RC, Kodner C, Coleman L. 1992. Cultivation of Borrelia burgdorferi from erythema migrans lesion and perilesional skin. J Clin Microbiol 30:359-361.
9. Bignami A, Stoolmiller AC. 1979. Astroglia-specific protein (GFA) in clonal cell lines derived form the F26 mouse glioma. Brain Res 163:353-357.
10. Burns MJ, Sellati TJ, Teng El, Furie MB. 1997. Production of interleukin-8 (IL-8) by cultured endothelial cells in response to Borrelia burgdorferi occurs independently of secreted [corrected] IL-1 and tumor necrosis factor alpha and is required for subsequent transendothelial migration of neutrophils [published erratum appears in Infect Immun 1997;65:2508]. Infect Immun 65:1217-1222.
11. Chandler S, Coates R, Gearing A, Lury J, Wells G, Bone E. 1995. Matrix metalloproteinases degrade myelin basic protein. Neurosci Lett 201:223-226.
12. Clark AW, Krekoski CA, Bou SS, Chapman KR, Edwards DR. 1997. Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia. Neurosci Lett 238:53-56.
13. Colton CA, Keri JE, Chen W-T, Monsky WL. 1993. Protease production by cultured microglia: substrate gel analysis and immobilized matrix degradation. J Neurosci Res 35:297-304.
14. Cossins JA, Clements JM, Ford J, Miller KM, Pigott R, Vos W, Van der Valk P, De Groot CJ. 1997. Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions. Acta Neuropathol 94:590-598.
15. Dahl D, Crossby CJ, Sethi JS, Bignami A. 1985. Glial fibrillary acidic (GFA) protein in vertebrates: immunfluorescence and immunoblotting study with monoclonal and polyclonal antibodies. J Comp Neurol 239:75-88.
16. Deb S, Gottschall PE. 1996. Increased production of matrix metalloproteinases in enriched astrocyte and mixed hippocampal cultures treated with beta-amyloid peptides. J Neurochem 66:1641-1647.
17. Dotevall L, Rosengren LE, Hagberg L. 1996. Increased cerebrospinal fluid levels of glial fibrillary acidic protein (GFAp) in Lyme neuroborreliosis. Infection 24:125-129.
18. Friedberg MH, Glantz MJ, Klempner MS, Cole BF, Perides G. 1998. Specific matrix metalloproteinase profiles in the cerebrospinal fluid correlated with the presence of malignant astrocytomas, brain metastases, and carcinomatous meningitis. Cancer 81:923-930.
19. Garcia-Monco JC, Benach JL. 1995. Lyme neuroborreliosis. Ann Neurol 37:691-702.
20. Garcia-Monco JC, Fernandez-Villar B, Benach JL. 1989. Adherence of the Lyme disease spirochaete to glial cells and cells of glial origin. J Infect Dis 160:497-506.
21. Garcia-Monco JC, Villar BF, Alen JC, Benach JL. 1990. Borrelia burgdorferi in the central nervous system: experimental and clinial evidence for early invasion. J Infect Dis 161:1187-1193.
22. Garcia-Monco JC, Villar BF, Szczepanski A, Benach JL. 1991. Cytotoxicity of Borrelia burgdorferi for cultured rat glial cells. J Infect Dis 163:1362-1366.
23. Garcia-Monco JC, Villar BF, Rogers RC, Szczepanski A, Wheeler CM, Benach JL. 1992. Borrelia burgdorferi and other related spirochaetes bind to galactocerebroside. Neurology 42:1341-1348.
24. Gijbels K, Masure S, Carton H, Opdenakker G. 1992. Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders. J Neuroimmunol 41:29-34.
25. Gijbels K, Galardy RE, Steinman L. 1994. Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibtor of matrix metalloproteases. J Clin Invest 94:2177-2182.
26. Giraudon P, Buart S, Bernard A, Thomasset N, Belin MF. 1996. Extracellular matrix-remodeling metalloproteinases and infection of the central nervous system with retrovirus human T-lymphotropic virus type I (HTLV-I). Progr Neurobiol 49:169-184.
27. Gottschall PE, Deb S. 1996. Regulation of matrix metalloproteinase expressions in astrocytes, microglia and neurons. Neuroimmunomodulation 3:69-75.
28. Halinen S, Sorsa T, Ding Y, Ingman T, Salo T, Konttinen YT, Saari H. 1996. Characterization of matrix metalloproteinase (MMP-8 and -9) activities in the saliva and in gingival crevicular fluid of children with Down's syndrome. J Periodontol 67:748-754.
29. Halperin JJ. 1995. Neuroborreliosis. Am J Med 98(Suppl 4A):52S-60S.
30. Halperin JJ, Volksman DJ, Wu P. 1991. Central nervous system abnormalities in Lyme neuroborreliosis. Neurology 41:1571-1582.
31. Imai K, Kusakabe M, Sakakura T, Nakanishi I, Okada Y. 1994. Susceptibility of tenascin to degradation by matrix metalloproteinases and serine proteinases. FEBS Lett 352:216-218.
32. Karlsson M, Hovind-Hougen K, Svenungsson B, Stiernstedt G. 1990. Cultivation and characterization of spirochaetes from cerebrospinal fluid of patients with Lyme borreliosis. J Clin Microbiol 28:473-479.
33. Kolb SA, Lahrtz F, Paul R, Leppert D, Nadal D, Pfister HW, Fontana A. 1998. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in viral meningitis: upregulation of MMP-9 and TIMP-1 in cerebrospinal fluid. J Neuroimmunol 84:143-50.
34. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
35. Lim GP, Backstrom JR, Cullen MJ, Miller CA, Atkinson RD, Tokes ZA. 1996. Matrix metalloproteinases in the neocortex and spinal cord of amyotrophic lateral sclerosis patients. J Neurochem 67:251-259.
36. Lyons JG, Birkedal-Hansen B, Moore WGI, O'Grady RL, Birkedal-Hansen H. 1991. Characteristics of a 95-kDa matrix metalloproteinase produced by mammary carcinoma cells. Biochemistry 30:1449-1456.
37. Lyons PD, Benveniste EN. 1998. Cleavage of membrane-associated ICAM-1 from astrocytes: involvement of a metalloprotease. Glia 22:103-112.
38. Ma Y, Weis JJ. 1993. Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokinestimulatory properties. Infect Immun 61:3843-3853.
39. Maeda A, Sobel RA. 1996. Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions. J Neuropathol Exp Neurol 55:300-309.
40. Matyszak MK, Perry VH. 1996. Delayed-type hypersensitivity lesions in the central nervous system are prevented by inhibitors of matrix metalloproteinases. J Neuroimmunol 69:141-149.
41. McCarthy KD, de Vellis J. 1980. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85:890-902.
42. Mentlein R, Ludwig R, Martensen I. 1998. Proteolytic degradation of Alzheimer's disease amyloid beta-peptide by a metalloproteinase from microglia cells. J Neurochem 70:721-726.
43. Miller EC, Isa S, Vannier E, Georgilis K, Steere AC, Dinarello CA. 1992. Live Borrelia burgdorferi preverentially activate interleukin-1β gene expression and protein synthesis over the inteleukin-1 receptor antagonist. J Clin Invest 90:906-912.
44. Moutsiakis D, Mancuso P, Krutzsch H, Stetler-Stevenson W, Zucker S. 1992. Characterization of metalloproteinases and tissue inhibitors of metalloproteinases in human plasma. Connect Tissue Res 28:213-230.
45. Nakagawa T, Kubota T, Kabuto M, Sato K, Kawano H, Hayakawa T, Okada Y. 1994. Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors. J Neurosurg 81:69-77.
46. Nocton JJ, Dressler F, Rutledge BJ, Rys PN, Persing DH, Steere AC. 1994. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N Engl J Med 330:229-234.
47. Nocton JJ, Bloom BJ, Rutledge BJ, Persing DH, Logigian EL, Schmid CH, Steere AC. 1996. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in cerebrospinal fluid in Lyme neuroborreliosis. J Infect Dis 174:623-627.
48. Nudel U, Zakut R, Shani M, Neuman S, Levy Z, Yaffe D. 1983. The nucleotide sequence of the rat cytoplasmic beta-actin gene. Nucleic Acids Res 11:1759-1771.
49. Pachner AR, Delaney E. 1993. The polymerase chain reaction in the diagnosis of Lyme neuroborreliosis. Ann Neurol 34:544-550.
50. Paul R, Lorenzl S, Koedel U, Sporer B, Vogel U, Frosch M, Pfister HW. 1998. Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis. Ann Neurol 44:592-600.
51. Perides G, Lane WS, Andrews D, Dahl D, Bignami A. 1989. Isolation and partial characterization of a glial hyaluronate-binding protein (GHAP). J Biol Chem 264:5981-5987.
52. Perides G, Hu G, Rueger DC, Charness ME. 1993. Osteogenic protein-1 regulates L1 and neural cell adhesion molecule gene expression in neural cells. J Biol Chem 268:25197-25205.
53. Perides G, Asher RA, Lark MW, Lane WS, Robinson RA. Bignami A. 1995. Glial hyaluronate-binding protein: a product of metalloproteinase digestion of versican? Biochem J 312:377-384.
54. Perides G, Charness ME, Tanner LM, Peter O, Satz N, Steere AC, Klempner MS. 1998. Matrix metalloproteinases in the cerebrospinal fluid of patients with Lyme neuroborreliosis. J Infect Dis 177:401-108.
55. Radolf JD, Norgard MV, Brandt ME, Isaacs RD, Thompson PA, Beutler B. 1991. Lipoproteins of Borrelia burgdorferi and Tryponema palldum activate chachectin/tumor necrosis factor synthesis. Analysis using a CAT reporter construct. J Immunol 147:1968-1974.
56. Rao JS, Yamamoto M, Mohaman S, Gokaslan ZL, Fuller GN, Stetler-Stevenson WG, Rao VH, Liotta LA, Nicolson GL, Sawaya RE. 1996. Expression and localization of 92 kDa type IV collagenase/gelatinase B (MMP-9) in human gliomas. Clin Exp Metast 14:12-18.
57. Reik L, Smith L, Khan A, Nelson W. 1985. Demyelinating encephalopathy in Lyme disease. Neurology 235:267-269.
58. Rosenberg GA. 1995. Matrix metalloproteinases in brain injury. J Neurotrauma 12:833-842.
59. Rosenberg GA, Dencoff JE, McGuire PG, Liotta LA, Stetler-Stevenson G. 1994. Injury-induced 92-kilodalton gelatinase and urokinase expression in rat brain. Lab Invest 71:417-422.
60. Rosenberg GA, Dencoff JE, Correa N Jr, Reiners M, Ford CC. 1996. Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury. Neurology 46:1626-32.
61. Sato H, Seiki M. 1996. Membrane-type matrix metalloproteinases (MT-MMPs) in tumor metastasis. J Biochem 119:209-215.
62. Sato H, Takino T, Okada Y, Cao J, shigarawa A, Yamamoto E, Seiki M. 1994. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370:61-65.
63. Steere AC. 1989. Lyme disease. N Engl J Med 321:586-596.
64. Tatro JB, Romero LI, Beassley D, Steere AC, Reichlin S. 1996. Borrelia burgdorferi and Escherichia coli lipopolysaccharides induce nitric oxide and inerleukin-6 production in cultured rat brain cells. J Infect Dis 169:1014-1022.
65. Towbin H, Stehelin T, Gordon J. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354.
66. Xia Y, Garcia G, Chen S, Wilson CB, Feng L. 1996. Cloning of rat 92-kDa type IV collagenase and expression of an active recombinant catalytic domain. FEBS Lett 382:285-288.
67. Yong VW, Krekoski CA, Forsyth PA, Bell R, Edwards DR. 1998. Matrix metalloproteinases and diseases of the CNS. Trends Neurosci 21:75-80.
68. Zhang JW, Gottschall PE. 1997. Zymographic measurement of gelatinase activity in brain tissue after detergent extraction and affinity-support purification. J Neurosci Methods 76:15-20.